Logo image of BFRG

BULLFROG AI HOLDINGS INC (BFRG) Stock Fundamental Analysis

NASDAQ:BFRG - Nasdaq - US12021E1091 - Common Stock - Currency: USD

1.73  +0.02 (+1.17%)

Fundamental Rating

1

Taking everything into account, BFRG scores 1 out of 10 in our fundamental rating. BFRG was compared to 36 industry peers in the Health Care Technology industry. The financial health of BFRG is average, but there are quite some concerns on its profitability. BFRG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BFRG has reported negative net income.
BFRG had a negative operating cash flow in the past year.
BFRG had negative earnings in each of the past 5 years.
In the past 5 years BFRG always reported negative operating cash flow.
BFRG Yearly Net Income VS EBIT VS OCF VS FCFBFRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

BFRG has a worse Return On Assets (-174.64%) than 86.11% of its industry peers.
With a Return On Equity value of -219.80%, BFRG is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -174.64%
ROE -219.8%
ROIC N/A
ROA(3y)-1273.22%
ROA(5y)-2623.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BFRG Yearly ROA, ROE, ROICBFRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -2K -4K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BFRG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BFRG Yearly Profit, Operating, Gross MarginsBFRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

More info and screens

5

2. Health

2.1 Basic Checks

BFRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BFRG has been increased compared to 1 year ago.
There is no outstanding debt for BFRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BFRG Yearly Shares OutstandingBFRG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M
BFRG Yearly Total Debt VS Total AssetsBFRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

BFRG has an Altman-Z score of 0.24. This is a bad value and indicates that BFRG is not financially healthy and even has some risk of bankruptcy.
BFRG has a Altman-Z score (0.24) which is in line with its industry peers.
A Debt/Equity ratio of 0.05 indicates that BFRG is not too dependend on debt financing.
BFRG has a Debt to Equity ratio (0.05) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 0.24
ROIC/WACCN/A
WACC10.37%
BFRG Yearly LT Debt VS Equity VS FCFBFRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M

2.3 Liquidity

BFRG has a Current Ratio of 4.86. This indicates that BFRG is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.86, BFRG belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
BFRG has a Quick Ratio of 4.86. This indicates that BFRG is financially healthy and has no problem in meeting its short term obligations.
BFRG has a Quick ratio of 4.86. This is amongst the best in the industry. BFRG outperforms 88.89% of its industry peers.
Industry RankSector Rank
Current Ratio 4.86
Quick Ratio 4.86
BFRG Yearly Current Assets VS Current LiabilitesBFRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

0

3. Growth

3.1 Past

BFRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.98%, which is quite good.
Looking at the last year, BFRG shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)8.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.89%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BFRG Yearly Revenue VS EstimatesBFRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 20K 40K 60K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BFRG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BFRG Price Earnings VS Forward Price EarningsBFRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BFRG Per share dataBFRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BFRG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BULLFROG AI HOLDINGS INC

NASDAQ:BFRG (6/18/2025, 8:00:01 PM)

1.73

+0.02 (+1.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners4.5%
Inst Owner Change45.83%
Ins Owners24.88%
Ins Owner Change-2.13%
Market Cap16.30M
AnalystsN/A
Price TargetN/A
Short Float %4.41%
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.02
P/tB 5.02
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.58
OCFYN/A
SpS0
BVpS0.34
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -174.64%
ROE -219.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1273.22%
ROA(5y)-2623.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.86
Quick Ratio 4.86
Altman-Z 0.24
F-Score2
WACC10.37%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.52%
OCF growth 3YN/A
OCF growth 5YN/A